Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Free PDFs:
Hepatology 2014 (5th Edition, 612 pages)
Short Guide to Hepatitis C (2014 Edition, 206 pages)

Free Abstracts

  Malignant Melanoma

  Free Subscription


08.09.2014

1 Am J Pathol
2 BMC Cancer
1 Br J Cancer
1 J Clin Oncol
2 J Invest Dermatol
4 Melanoma Res
1 Oncogene
1 Oncol Rep
1 PLoS Comput Biol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. KOBAYASHI T, Hamaguchi Y, Hasegawa M, Fujimoto M, et al
    B Cells Promote Tumor Immunity against B16F10 Melanoma.
    Am J Pathol. 2014 Aug 27. pii: S0002-9440(14)00420.
    PubMed     Text format     Related articles    Abstract available


    BMC Cancer

  2. IHLE MA, Fassunke J, Konig K, Grunewald I, et al
    Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations.
    BMC Cancer. 2014;14:13.
    PubMed     Text format     Related articles    Abstract available

  3. OLIVEIRA CS, de Bock CE, Molloy TJ, Sadeqzadeh E, et al
    Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.
    BMC Cancer. 2014;14:630.
    PubMed     Text format     Related articles    Abstract available


    Br J Cancer

  4. FEDORENKO IV, Gibney GT, Sondak VK, Smalley KS, et al
    Beyond BRAF: where next for melanoma therapy?
    Br J Cancer. 2014 Sep 2. doi: 10.1038/bjc.2014.
    PubMed     Text format     Related articles    Abstract available


    J Clin Oncol

  5. PERIER-MUZET M, Thomas L, Dalle S
    Safety and Management of New Primary Melanomas During Receipt of BRAF Inhibitors.
    J Clin Oncol. 2014 Sep 2. pii: JCO.2014.55.0590.
    PubMed     Text format     Related articles   


    J Invest Dermatol

  6. DAHL C, Abildgaard C, Riber-Hansen R, Steiniche T, et al
    KIT is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma.
    J Invest Dermatol. 2014 Sep 1. doi: 10.1038/jid.2014.
    PubMed     Text format     Related articles    Abstract available

  7. WROBEL LJ, Anne Le Gal F
    Inhibition of Human Melanoma Growth by a Non-Cardioselective Betablocker.
    J Invest Dermatol. 2014 Sep 1. doi: 10.1038/jid.2014.
    PubMed     Text format     Related articles    Abstract available


    Melanoma Res

  8. CHIARUGI A, Quaglino P, Crocetti E, Nardini P, et al
    Melanoma density and relationship with the distribution of melanocytic naevi in an Italian population: a GIPMe study - the Italian multidisciplinary group on melanoma.
    Melanoma Res. 2014.
    PubMed     Text format     Related articles    Abstract available

  9. PETERS S, Bouchaab H, Zimmerman S, Bucher M, et al
    Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient.
    Melanoma Res. 2014;24:496-500.
    PubMed     Text format     Related articles    Abstract available

  10. SANCHEZ-MUNOZ A, Navarro-Perez V, Alonso L, Moreno I, et al
    Adjuvant high-dose interferon therapy for melanoma: nothing has really changed.
    Melanoma Res. 2014;24:522-3.
    PubMed     Text format     Related articles   

  11. STRICKLER AG, Vasquez JG, Yates N, Ho J, et al
    Potential diagnostic significance of HSP90, ACS/TMS1, and L-plastin in the identification of melanoma.
    Melanoma Res. 2014.
    PubMed     Text format     Related articles    Abstract available


    Oncogene

  12. LEUFKE C, Leykauf J, Krunic D, Jauch A, et al
    The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas.
    Oncogene. 2014;33:3506-18.
    PubMed     Text format     Related articles    Abstract available


    Oncol Rep

  13. ANDRE ND, Silva VA, Watanabe MA, De Lucca FL, et al
    Intratumoral injection of PKR shRNA expressing plasmid inhibits B16-F10 melanoma growth.
    Oncol Rep. 2014 Aug 18. doi: 10.3892/or.2014.3410.
    PubMed     Text format     Related articles    Abstract available


    PLoS Comput Biol

  14. BERNARDO-FAURA M, Massen S, Falk CS, Brady NR, et al
    Data-derived modeling characterizes plasticity of MAPK signaling in melanoma.
    PLoS Comput Biol. 2014;10:e1003795.
    PubMed     Text format     Related articles    Abstract available


    PLoS One

  15. MIGNOT G, Hervieu A, Vabres P, Dalac S, et al
    Prospective Study of the Evolution of Blood Lymphoid Immune Parameters during Dacarbazine Chemotherapy in Metastatic and Locally Advanced Melanoma Patients.
    PLoS One. 2014;9:e105907.
    PubMed     Text format     Related articles    Abstract available

  16. NOTEBAERT L, Chrystal J, Clarke PJ, Holmes EA, et al
    When we should worry more: using cognitive bias modification to drive adaptive health behaviour.
    PLoS One. 2014;9:e85092.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: